Pharmalink initiates a pivotal Phase IIb trial with Nefecon® in patients with primary IgA nephropathy December 18, 2012 15:24 CET Non Regulatory Read more
Pharmalink enters manufacturing agreement for Nefecon® October 31, 2012 15:23 CET Non Regulatory Read more